Scil Technology assets bought out by Nanohale

Nanohale, a German firm developing new formulations of protein and peptide therapeutics, has acquired the R&D and contract development and manufacturing services assets of Scil Technology, bringing them into a new wholly owned subsidiary called Formycon.

Nanohale, a German firm developing new formulations of protein and peptide therapeutics, has acquired the R&D and contract development and manufacturing services assets of Scil Technology, bringing them into a new wholly owned subsidiary called Formycon.

Scil Technology itself will remain as an independent company with rights to the tissue regeneration projects outlicensed to Medtronic (the...

More from Musculoskeletal

More from Therapeutic Category